Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Jiuyang Xu and Lianhan Shang.
Jiuyang Xu
Connection Strength
0.904
Lianhan Shang
  1. The Effect of Prior Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Treatment on Coronavirus Disease 2019 (COVID-19) Susceptibility and Outcome: A Systematic Review and Meta-analysis. Clin Infect Dis. 2021 06 01; 72(11):e901-e913.
    View in: PubMed
    Score: 0.237
  2. Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis. Front Med. 2020 Oct; 14(5):601-612.
    View in: PubMed
    Score: 0.223
  3. Guarding a city from the COVID-19 pandemic. Lancet Digit Health. 2020 06; 2(6):e275-e276.
    View in: PubMed
    Score: 0.220
  4. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021 01 16; 397(10270):220-232.
    View in: PubMed
    Score: 0.058
  5. Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19. Clin Microbiol Infect. 2021 Jan; 27(1):112-117.
    View in: PubMed
    Score: 0.057
  6. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020 05 16; 395(10236):1569-1578.
    View in: PubMed
    Score: 0.055
  7. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020 05 07; 382(19):1787-1799.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.